List of Excipients in API naloxone hydrochloride
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing naloxone hydrochloride
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | HYDROCHLORIC ACID | |
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | SODIUM CHLORIDE | |
| Adamis Pharmaceuticals | ZIMHI | naloxone hydrochloride | 38739-600 | WATER | |
| A-S Medication Solutions | NARCAN | naloxone hydrochloride | 50090-2422 | BENZALKONIUM CHLORIDE | |
| A-S Medication Solutions | NARCAN | naloxone hydrochloride | 50090-2422 | EDETATE DISODIUM | |
| A-S Medication Solutions | NARCAN | naloxone hydrochloride | 50090-2422 | HYDROCHLORIC ACID | |
| A-S Medication Solutions | NARCAN | naloxone hydrochloride | 50090-2422 | SODIUM CHLORIDE | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing naloxone hydrochloride
Detailed excipient profiles for naloxone hydrochloride
Excipient focus: BENZALKONIUM CHLORIDE
naloxone hydrochloride drug variants containing BENZALKONIUM CHLORIDE
naloxone hydrochloride drug variants not containing BENZALKONIUM CHLORIDE
Excipient focus: EDETATE DISODIUM
naloxone hydrochloride drug variants containing EDETATE DISODIUM
naloxone hydrochloride drug variants not containing EDETATE DISODIUM
Excipient focus: HYDROCHLORIC ACID
naloxone hydrochloride drug variants containing HYDROCHLORIC ACID
naloxone hydrochloride drug variants not containing HYDROCHLORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Lake Erie Medical DBA Quality Care Products LLC | naloxone hydrochloride | 55700-457 |
| Mylan Institutional LLC | naloxone hydrochloride | 67457-992 |
| International Medication Systems Ltd | naloxone hydrochloride | 76329-3669 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
naloxone hydrochloride drug variants containing METHYLPARABEN
naloxone hydrochloride drug variants not containing METHYLPARABEN
Excipient focus: NITROGEN
naloxone hydrochloride drug variants containing NITROGEN
| Company | Ingredient | NDC |
|---|---|---|
| Dr Reddys Laboratories Inc | naloxone hydrochloride | 43598-750 |
| HF Acquisition Co LLC DBA HealthFirst | naloxone hydrochloride | 51662-1529 |
| >Company | >Ingredient | >NDC |
naloxone hydrochloride drug variants not containing NITROGEN
Excipient focus: PROPYLPARABEN
naloxone hydrochloride drug variants containing PROPYLPARABEN
naloxone hydrochloride drug variants not containing PROPYLPARABEN
Excipient focus: SODIUM CHLORIDE
naloxone hydrochloride drug variants containing SODIUM CHLORIDE
naloxone hydrochloride drug variants not containing SODIUM CHLORIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
naloxone hydrochloride drug variants containing SODIUM HYDROXIDE
naloxone hydrochloride drug variants not containing SODIUM HYDROXIDE
Excipient focus: TRISODIUM CITRATE DIHYDRATE
naloxone hydrochloride drug variants containing TRISODIUM CITRATE DIHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Harm Reduction Therapeutics Inc | naloxone hydrochloride | 82954-0100 |
| >Company | >Ingredient | >NDC |
naloxone hydrochloride drug variants not containing TRISODIUM CITRATE DIHYDRATE
Excipient focus: WATER
naloxone hydrochloride drug variants containing WATER
naloxone hydrochloride drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
